BioTech/Drugs - Raleigh, NC, US
Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological disorders. Innovate is currently developing two clinical stage assets: > INN-329 in phase III for Magnetic Resonance Cholangiopancreatography (MRCP) > INN-108 in phase II for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to both products backed by more than 70 patents across the US, EU and Japan.
Outlook
Mobile Friendly
Amazon AWS